Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Botulinum toxin by Huons for Unspecified Musculoskeletal Disorders: Likelihood of Approval
Botulinum toxin is under clinical development by Huons and currently in Phase III for Unspecified Musculoskeletal Disorders. According to GlobalData,...